Clinical Trials
4 trialsNCT01309490 2025-07-29
Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients
Jewish General Hospital
Phase 1/2 Terminated
NCT01056523 2023-10-02
Use of Ribavirin and Low Dose Ara-C to Treat Acute Myeloid Leukemia
Jewish General Hospital
Phase 1/2 Completed
NCT03760666 2022-08-08
A Study of Brequinar in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
Clear Creek Bio, Inc.
Phase 1/2 Terminated
NCT01056757 2015-11-04
Treatment With Ribavirin for Patients With Metastatic Breast Cancer
Jewish General Hospital
Phase 1/2 Terminated